La Jolla Pharmaceutical Co.

Company Website

6455 Nancy Ridge Dr.
San Diego, CA 92121

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

La Jolla Pharmaceutical Co.

Market Cap as of 6/12/2015

$350,006,784

Market Cap as of 7/03/2014

$70,568,775

Market Cap as of 07/02/2013

$2,286,467

Market Cap as of 06/26/2012

$727,999

Market Cap as of 01/04/2012

$197,853

Market Cap as of 06/20/2011

Market Cap as of 01/06/2011

$3,788,402

Exchange and Ticker Symbol

OTC US: LJPC

Fields of Research

Focuses on the development of a novel class of compounds known as Regenerative Immunophilin Ligands (RILs) in the field of regenerative medicine

Major Products

LJP1485

Executives

Deirdre Gillespie (profile)

  • Chief Executive Officer
  • President

George Tidmarsh

  • Chief Executive Officer
  • President

Similar Companies

In-Vitro Diagnostic Substance Manufacturing325413
IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES2835
Aircraft Manufacturing336411
AIRCRAFT3721
Other Aircraft Parts and Auxiliary Equipment Manufacturing336413
AIRCRAFT PARTS AND AUXILIARY EQUIPMENT, NOT ELSEWHERE CLASSIFIED3728
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)541712
AIRCRAFT3721